Aflac Incorporated (AFL) - Stock Report

Aflac Incorporated experienced a top-line contraction in the fiscal year ended December 2025, with total revenue declining -8.9% to $17.4 billion. This scale reduction led to operating margin compression from 33.6% to 26.7%, while net margin fell from 28.5% to 21.0%. Despite these profitability pressures, the business maintained capital-efficient cash generation, delivering $2.6 billion in operating cash flow against zero capital expenditures, which supported net financing outflows of $4.1 billion.

The business model centers on underwriting third-sector insurance products, such as cancer and medical policies, which are designed to cover out-of-pocket expenses not reimbursed by primary health insurance systems. Aflac Japan serves as the principal contributor to consolidated earnings, leveraging its position as the largest insurer in Japan for cancer and medical policies in force to capture stable, high-margin premium income.

The operating model relies on highly diversified, capital-efficient distribution networks to drive policy growth. In Japan, Aflac Incorporated utilizes a vast agency network alongside strategic alliances with major institutions, including Japan Post Group, Dai-ichi Life, and Daido Life, which collectively provide access to tens of thousands of sales outlets. In the United States, the company distributes its portable supplemental policies primarily through independent career agents targeting the small-business worksite market, complemented by broker channels for mid-to-large corporate clients and expanding digital lead generation.

Strategic priorities focus on mitigating macroeconomic sensitivities and adapting to regulatory evolutions, such as the economic value-based solvency regime in Japan. Management continues to emphasize product innovation, exemplified by the 2025 launches of the Miraito cancer product and the Anshin Palette medical product, to sustain premium growth. Ultimately, Aflac Incorporated's business model delivers strong cash durability and high profitability, characterized by an operating margin of 29.6% and a profit margin of 25.6%, which support consistent shareholder returns through dividends and capital allocation.